宝丹酮300mg BOLD-300
宝丹酮BOLD 300 (Boldenone undecylenate) is an injectable steroid that exhibits strong anabolic and moderately androgenic properties. The well-balanced anabolic and androgenic properties of this drug are greatly appreciated by athletes, who want to enhance their result without strong side effects.
Boldenone greatly stimulates hematopoiesis. Elevated levels of red blood cells improve oxygen delivery to the muscles.
宝丹酮BOLD 300 (Boldenone undecylenate) is an injectable steroid that exhibits strong anabolic and moderately androgenic properties. The well-balanced anabolic and androgenic properties of this drug are greatly appreciated by athletes, who want to enhance their result without strong side effects.
Boldenone has an incredibly long active life, requiring less frequent injections and is often used as a part of very long cycles.
相关产品
庚酸美替诺龙|注射美替|PRIM 100|Pharmacom
托瑞米芬 FARESTOS
托瑞米芬,Farestos (active agent - toremifene citrate) is a selective estrogen receptor modulator (SERM) derived from triphenylethylene. Toremifene was patented and approved in Europe in the mid 1990's to treat metastatic ER+ breast cancer in postmenopausal women.
In bodybuilding, toremifene citrate is used by men as a drug for post-cycle therapy (PCT) to counteract and/or block some of the effects of excessive estradiol in the body obtained through aromatization of various androgens used. Toremifene is used particularly to restore levels of endogenous testosterone in blood, as well as to prevent the estrogen-related side effect of gynecomastia.
注射康复龙 OXY50
注射康复龙,Oxymetholone (also known as anapolon or anadrol) is a very drastic synthetic steroid, 17-alpha-alkylated modification of dihydrotestosterone. It was developed for the treatment of osteoporosis and anaemia, as well as to stimulate muscle gain in malnourished and debilitated patients. Oxymetholone has been approved by the American Food and Drug Administration (FDA) for use in humans. Later there where created non-steroidal drugs that effectively could treat anaemia and osteoporosis; because of this anapolon lost his popularity and by 1993 Syntex decided to cease the production of the drug, as well as other manufacturers did.